Fewer Biotech-Pharma M&As But Tie-ups Indicate New China Trends

 
• By Dexter Jie Yan
  
Two arrows joining
Chinese biotechs and major pharma converged in a shared innovation drive in 2022 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia